Risk Factors for Febrile Neutropenia in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Undergoing Initial R-CHOP Treatment
Patients with DLBCL who develop FN after their first R-CHOP treatment have a significantly worse OS than those without FN. Tailored prophylaxis with granulocyte-colony stimulating factor and antibiotics may be essential in this population. Models with moderate to strong predictive power can be designed using various artificial intelligence techniques.
Authors
- Liang-Ying Chen
- Che-An Tsai
- Yu‐Chen Su (ORCID: https://orcid.org/0000-0001-8687-4355)
- C H Lin
- Chieh-Lin Jerry Teng
- Po-Wei Liao
- Ling-Chiao Teng
Institutions
- National Chung Hsing University (TW)
- Tunghai University (TW)
- Taichung Veterans General Hospital (TW)
- Chung Shan Medical University (TW)
Publication Details
- Journal
- Clinical Medicine Insights Oncology
- Published
- 2026-02-18
- DOI
- https://doi.org/10.1177/11795549261423995
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00